Nasdaq: ATTO · Listed Aug 5, 2026
Attovia Therapeutics IPO
IPO price
$17.00
Attovia Therapeutics (ATTO) priced its IPO at $17.00 a share and has traded on Nasdaq since Aug 5, 2026.
ATTO today$15.53-8.65%since IPO15-min delayed · as of 5:19:45 PM EST on Nov 18, 2026
See the ATTO quoteFirst trading day · Aug 5, 2026
- IPO price
- $17.00
- the top of the range of $15 to $17
- First trade
- $21.00
- +23.53% from the IPO price
- First-day last trade
- $21.96
- +29.18% from the IPO price, regular session
- Raise
- $289M
- before the underwriters' option
These numbers are from the first trading day, Aug 5, 2026.
How ATTO did against the market
ATTO against the market, from its first trade at 12:15 ET to the last trade of the session.
- ATTO from its first trade
- +4.57%
- Against the market (QQQ)
- +5.0 pts
ATTO rose 4.6% from its first trade to the last trade of the session. That is 5.0 points better than the market.
Same-day moves do not show that ATTO caused them. The market is QQQ, the Nasdaq-100 ETF.
The debut race
ATTO against other big listings, as the percent change from each stock's own IPO price.
The first 30 trading days. Each point is the last regular-session trade of a day.
The first trading day.
The first trading day.
The IPO scoreboard
ATTO against 6 other big listings: the return from each IPO's own price at the first trade, the close of day 1, day 5, and day 30.
| IPO | Raised | First trade | Day 1 close | Day 1 close, as a bar | Day 5 | Day 30 |
|---|---|---|---|---|---|---|
| Attovia Therapeutics '26 | $289M | +23.53% | +29.18% | +10.06% | +29.79% | |
| Figma '25 | $1.22B | +157.58% | +252.42% | +173.64% | +69.64% | |
| Circle '25 | $1.05B | +122.58% | +168.45% | +278.18% | +622.98% | |
| Reddit '24 | $748M | +38.24% | +47.97% | +69.90% | +40.32% | |
| Arm '23 | $5.23B | +10.00% | +23.76% | +3.63% | -3.06% | |
| Klarna '25 | $1.37B | +30.00% | +16.14% | +13.73% | -7.33% | |
| CoreWeave '25 | $1.5B | -2.50% | +0.02% | +34.32% | +28.42% |
Day 1 is the last regular-session trade of the first day. Day 5 and day 30 are the last trade of the fifth and thirtieth trading day, counting the listing day as day 1. A cell fills in when that day has traded.
The offering
The Attovia Therapeutics IPO offers 17M shares to raise $289M, before any underwriters' option.
- Expected price range
- $15 to $17
- IPO price
- $17.00
- Shares offered
- 17M
- Money raised
- $289M
- Listing date
- Aug 5, 2026
- Exchange
- Nasdaq
- Security
- Ordinary Shares
Money raised, against the largest IPOs
- Alibaba '14$21.77B
- Facebook '12$18.41B
- Rivian '21$11.93B
- Uber '19$8.1B
- Arm '23$5.23B
- Attovia Therapeutics$289M
Where ATTO ranks
Attovia Therapeutics's market cap against the largest US-listed companies.
Market cap, against the largest US-listed companies
- AAPL$5.12T
- MSFT$3.77T
- NVDA$3.65T
- GOOGL$3.47T
- AMZN$2.9T
- TSM$1.88T
- AVGO$1.69T
- META$1.58T
- TSLA$1.52T
- BRK.B$1.22T
- ATTO$709.92M
ATTO news
The latest news and headlines about Attovia Therapeutics (ATTO).
- Why Nocera Are Trading Higher By Around 89%; Here Are 20 Stocks Moving PremarketBenzinga· Jul 5, 2023
- Why Li Auto Shares Are Trading Higher By Around 7%? Here Are Other Stocks Moving In Monday's SessionBenzinga· Jul 3, 2023
- Nasdaq Edges Lower; ISM Manufacturing PMI Drops In JuneBenzinga· Jul 3, 2023
- Why Nvidia Shares Are Trading Higher By Over 5%? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionBenzinga· May 30, 2023
- Penny Stocks To Buy? 3 AI Stocks To Watch Right NowPennyStocks· May 30, 2023
- Why Seelos Therapeutics Shares Are Trading Lower By 10%; Here Are 20 Stocks Moving PremarketBenzinga· May 30, 2023
Filings and the company
What Attovia Therapeutics has disclosed to the SEC, and the basic facts about the listing.
8-K filings
Material events that Attovia Therapeutics discloses to the SEC on Form 8-K.
- Clinical trial resultsNov 9, 2026
The Company recently announced positive topline 12-week results from its Phase 1b study of ATTO-1310, a next-generation anti-IL-31 ATTOBODY-based precision itch therapy, in patients with chronic pruritus ("CP") and high-itch atopic dermatitis ("AD").
- Quarterly earningsSep 2, 2026
On September 2, 2026, Attovia Therapeutics, Inc. (the "Company") issued a press release reporting its financial results for the second quarter ended June 30, 2026.
- Charter amendmentAug 6, 2026
On August 6, 2026, Attovia Therapeutics, Inc. (the "Company") filed its Amended and Restated Certificate of Incorporation (the "Charter") with the Secretary of State of the State of Delaware...in connection with the closing of the initial public offering (the "Offering") of shares of the Company's common stock.
About Attovia Therapeutics
Attovia Therapeutics Inc is a clinical stage biotechnology company focused on research and development of therapeutic products in the fields of immune-mediated diseases. Its product pipeline includes ATTO-1310 and ATTO-2306 for immune-dermatology indications and ATTO-1091 for inflammatory diseases, including inflammatory bowel disease (IBD). The company's product candidates are developed using its ATTOBODY biologics platform.
- Ticker
- ATTO
- Exchange
- Nasdaq
- Market
- stocks
- Type
- CS
- Currency
- USD
- Industry
- BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
- Listed
- Aug 5, 2026
- Security
- Ordinary Shares
Frequently asked questions
What was the Attovia Therapeutics IPO price?
$17.00 a share.
When did Attovia Therapeutics go public?
Attovia Therapeutics listed on Nasdaq on Aug 5, 2026 under the ticker ATTO.
How much did the Attovia Therapeutics IPO raise?
$289M, before any underwriters' option.
How did Attovia Therapeutics open on its first day?
ATTO first traded at $21.00, +23.53% from the IPO price of $17.00.
How did ATTO close on its first day?
Its last regular-session trade was $21.96, +29.18% from the IPO price of $17.00.
What was the ATTO first-day trading range?
$20.21 to $22.79 in the regular session.
How many ATTO shares traded on the first day?
4.71M shares in the regular session.
How many shares did Attovia Therapeutics sell in its IPO?
17M shares.
How did ATTO do against the market on its first day?
ATTO rose 4.6% from its first trade to the last trade of the session. That is 5.0 points better than the market (QQQ, the Nasdaq-100 ETF).
What exchange is ATTO listed on?
Attovia Therapeutics lists on Nasdaq under the ticker ATTO.
Build with Massive
Get the ATTO data behind this page
| What the page shows | Endpoint |
|---|---|
| Offering terms and dates | /vX/reference/ipos |
| Price | /v3/snapshot |
| Chart, VWAP, and the market comparison | /v2/aggs/ticker/ATTO/range/5/minute |
| Market cap | /v3/reference/tickers/ATTO |
| News | /v2/reference/news |
| Filings | /vX/disclosures |
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.